ZY-19489

CAS No. 1821293-40-6

ZY-19489( —— )

Catalog No. M35924 CAS No. 1821293-40-6

ZY-19489 is an antimalarial compound that is a potential single-dose cure for Plasmodium falciparum and Plasmodium vivax malaria. It has received orphan drug designation from the FDA.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 555 Get Quote
5MG 833 Get Quote
10MG 1121 Get Quote
25MG 1647 Get Quote
50MG 2199 Get Quote
100MG 2925 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ZY-19489
  • Note
    Research use only, not for human use.
  • Brief Description
    ZY-19489 is an antimalarial compound that is a potential single-dose cure for Plasmodium falciparum and Plasmodium vivax malaria. It has received orphan drug designation from the FDA.
  • Description
    Sutidiazine (ZY-19489) is an orally active and antimalarial agent. Sutidiazine inhibits parasitemia-induced infection. Sutidiazine shows short half-lives (approximately 7 h) and an exposure effect.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Parasite
  • Recptor
    Parasite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1821293-40-6
  • Formula Weight
    465.57
  • Molecular Formula
    C24H32FN9
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C=1C(=CN=C(NC2=CC(=C(F)C(C)=N2)C3CC3)N1)N4C[C@@H](C)N(C)CC4)C=5C=C(C)N(C)N5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ghoghari AM, et al. Simultaneous estimation of ZY-19489 and its active metabolite?ZY-20486 in human plasma using LC-MS/MS, a novel antimalarial compound. Bioanalysis. 2021 Dec;13(23):1761-1777.?
molnova catalog
related products
  • Antimalarial agent 3...

    Antimalarial agent 30 has anti-Plasmodium berghei liver stage parasite activity and antimalarial activity for the study of malarial infections.

  • YCN47284

    YCN47284 is an antimalarial compound with an IC50 of 1 μM for P. falciparum.

  • GNF179

    GNF179 is an optimized 8,8-dimethyl IP analog.